Statistics

Total Visits

Views
Phase II study of dovitinib in first line metastatic or (non resectable primary) adrenocortical carcinoma (ACC) - SOGUG study 2011-039

Select a period of time:

Number of views in the range

Views
Phase II study of dovitinib in first line metastatic or (non resectable primary) adrenocortical carcinoma (ACC) - SOGUG study 2011-035

Views

Views
November 20230
December 20230
January 20242
February 20240
March 20241
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Boardman1